James H. MacKaness
Net Worth

Last updated:

What is James H. MacKaness net worth?

The estimated net worth of Mr. James H. MacKaness is at least $6,453,837 as of 1 Jul 2024. He owns shares worth $3,725,526 as insider, has earned $1,932,351 from insider trading and has received compensation worth at least $795,960 in Soleno Therapeutics, Inc..

What is the salary of James H. MacKaness?

Mr. James H. MacKaness salary is $198,990 per year as Chief Financial Officer in Soleno Therapeutics, Inc..

How old is James H. MacKaness?

Mr. James H. MacKaness is 61 years old, born in 1964.

What stocks does James H. MacKaness currently own?

As insider, Mr. James H. MacKaness owns shares in one company:

Company Title Shares Price per share Total value
Soleno Therapeutics, Inc. (SLNO) Chief Financial Officer 55,763 $66.81 $3,725,526

What does Soleno Therapeutics, Inc. do?

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

SLNO logo
SLNO
Soleno Therapeutics, Inc.
$66.81

James H. MacKaness insider trading

Soleno Therapeutics, Inc.

Mr. James H. MacKaness has made 10 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,568 units of SLNO stock worth $64,636 on 1 Jul 2024.

The largest trade he's ever made was exercising 40,000 units of SLNO stock on 31 Mar 2022. As of 1 Jul 2024 he still owns at least 55,763 units of SLNO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,568 $41.22 $64,636
Sale
Common Stock 5,622 $41.63 $234,016
Sale
Common Stock 3,104 $41.12 $127,646
Sale
Common Stock 2,071 $41.67 $86,292
Option
Employee stock option (right to buy) 15,000 $2.6 $38,925
Option
Common Stock 15,000 $2.6 $38,925
Sale
Common Stock 13,849 $37.07 $513,313
Sale
Common Stock 12,381 $36.16 $447,660
Sale
Common Stock 6,252 $35.49 $221,865
Sale
Common Stock 4,186 $28.65 $119,937
Sale
Common Stock 2,162 $27.43 $59,297
Sale
Common Stock 2,041 $28.27 $57,689
Purchase
Common Stock 40,000 N/A N/A
Purchase
Warrant (right to buy) 40,000 $0.3 $12,000
Purchase
Common Stock 11,235 $0.89 $9,977

Soleno Therapeutics key executives

Soleno Therapeutics, Inc. executives and other stock owners filed with the SEC: